PATENT CLAIM ANALYSIS

Application Number: 15780980
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.

Claim (Index 24):
The method as set forth in  claim 12  wherein the neovascular eye disease is selected from the group consisting of coreneal neovascularization, retinal neovascularization, and wherein the synthetic compound comprises the formula

Metadata:
- Claim Count in Document: 10.0
- Percentile: 94.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15889409', '14833041', '15512200', '15602096', '15058938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7354456747587765
- 35 USC 102 Novelty (BERT): 0.5490766846562638
- Combined Prediction Score: 0.7168087757485252
- Mean Citation Score: 319.820838
- Max Citation Score: 421.37485
- Similarity Product: 298.2598562582642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test